| Dr Melina Alexis Harmelin, MD | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-2232 | |
| Not Available |
| Full Name | Dr Melina Alexis Harmelin |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942461306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 0116020581 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melina Alexis Harmelin, MD 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-2232 | Dr Melina Alexis Harmelin, MD 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-2232 |
News Archive
Every year, thousands of babies are born with severely malformed hearts, disorders known collectively as congenital heart disease. Many of these defects can be repaired though surgery, but researchers don't understand what causes them or how to prevent them. New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Long-term exposure to the combination of even modestly lower LDL cholesterol (LDL-C) and systolic blood pressure (SBP) has the potential to "dramatically reduce" a person's lifetime risk of cardiovascular disease, according to new findings reported at ESC Congress 2016.
By investigating a rare and severe form of diabetes in children, University of Iowa researchers have discovered a new molecular mechanism that regulates specialized pancreatic cells and insulin secretion. The mechanism involves a protein called ankyrin, which UI researchers previously linked to potentially fatal human heart arrhythmias.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the U.S. Food & Drug Administration (FDA) has provided Orphan Drug Designation to ALN-TTR02 as a therapeutic for the treatment of familial amyloidotic polyneuropathy (FAP), one of the predominant clinical manifestations of transthyretin (TTR)-mediated amyloidosis (ATTR).
Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.
› Verified 8 days ago
Sarah Marakos, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-6652 | |
Dr. Raul A Lazarte, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-289-1400 Fax: 703-289-1414 | |
Dr. Tong S Park, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-289-1400 Fax: 703-289-1414 | |
Dr. Fegegta A Workie, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-289-1400 Fax: 703-289-1414 | |
Dr. Tru Van Le, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6404 Seven Corners Pl Ste F, Falls Church, VA 22044 Phone: 703-241-5695 Fax: 703-237-9896 | |
Dr. Bassam A. Atiyeh, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 107 N Virginia Ave, Falls Church, VA 22046 Phone: 703-532-4446 Fax: 703-532-8426 | |
Dr. Robin Yates Dulman, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6565 Arlington Blvd, Suite 200, Falls Church, VA 22042 Phone: 703-531-3627 Fax: 703-531-1590 |